載入...
PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer
SIMPLE SUMMARY: Over the last decade, immune checkpoint inhibitors (ICIs) targeting programmed death 1 (PD-1), programmed death-ligand 1 (PD-L1), and cytotoxic T-lymphocyte antigen 4 (CTLA-4) have dramatically changed the therapeutic algorithm of several hematological and solid tumors. Of note, thes...
Na minha lista:
| 發表在: | Cancers (Basel) |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7867133/ https://ncbi.nlm.nih.gov/pubmed/33535621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13030558 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|